RT Journal Article
SR Electronic
A1 Powers, Jenny
T1 The Role of Biosimilar and Orphan Drugs in Treating Patients with Rheumatologic Disease
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 17
SP 6
OP 8
DO 10.1177/155989771417001
UL http://mdc.sagepub.com/content/14/17/6.abstract
AB Biosimilar drugs may offer affordable targeted therapies to patients across a spectrum of rheumatologic, oncologic, and gastrointestinal diseases, but they pose unique clinical trial design and licensing issues. Governments provide incentives for developing orphan drugs that would not otherwise be cost-effective to manufacture, allowing for the possibility of effective treatment options for rare diseases, including many rheumatologic conditions.